Industry: Pharmaceuticals, Biotechnology
BioSignia, Inc. is a life sciences research organization that specializes in understanding the epidemiology of slowly developing multifactor diseases. The company develops cutting-edge predictive technologies for determining risk for morbidity and/or mortality and embeds these technologies in comprehensive systems that augment decisions related to patient care, drug development and marketing, and actuarial sciences. ( www.biosignia.com )
BioSignia Inc
1822 East NC Highway 54 Suite 350
Durham, North Carolina 27713
USA
Tel: (919) 933-2021
Fax: (919) 968-9413